Clinical Signs for Differential Diagnosis of Eyelid Tumours

Abstract

This article aims to present the differential diagnostics of benign and malignant eyelid tumours. The most common malignant eyelid tumour is basal cell carcinoma, followed by squamous cell carcinoma. The common signs of malignity are loss of lashes, ulceration, and infiltration of the lesion. Often the clinical appearance is various and therefore only a histological analysis gives the proper diagnosis. For most tumours, surgical resection is the gold standard of therapy. The reconstruction of the defects should be performed by an experienced oculoplastic surgeon. In malignant tumours that require large safety margins, the defect can be easily very large, and the reconstruction must then be performed with advanced ophthalmic plastic reconstruction techniques.

Are we Capable of Contributing to the Reduction of Eyelid Basal Cell Carcinoma? Building a Healthcare Team

“…On the other hand, secondary prevention entails a targeted approach to enable early detection of skin cancer lesions, facilitating timely interventions aimed at impeding disease progression and improving patient outcomes [3,14]. Accordingly, health literacy paramount importance in enabling patients to recognise primary lesions, while also equipping healthcare professionals with their specialised knowledge to deliver accurate information for differentiating between benign and malignant tumours [18][19][20]. For instance, eyelid basal cell carcinoma can be present in different forms.…”

Tumoren der Augenlider und der Orbita – aktuelle Aspekte in Diagnostik und Therapie

“…Im ersten Beitrag stellt Herr Adam Kopecky aus der Universitätsaugenklinik Köln "Klinische Zeichen zur Differenzialdiagnose von Augenlidtumoren" dar [1]. Als wichtige Malignitätskriterien sind der Verlust der Wimpern, die sogenannte Madarosis, aber auch Ulzerationen und insbesondere die dokumentierte Größenprogression wegweisend [1].…”